EIS Organising Committee

Mr. Alistair Laidlaw
President
EURETINA

PROF. RAMIN TADAYONI
PRESIDENT ELECT
EURETINA

Prof. Anat Loewenstein
General Secretary
EURETINA

Dr. Kourous Rezaei
Co-opted Board Member
EURETINA

Prof. Frank Holz
Past President
EURETINA

DARA CONLON
EXECUTIVE VICE-PRESIDENT
EURETINA
Contributors
Euretina is delighted to announce the following speakers and panellists confirmed to participate in the Inaugural EURETINA Innovation Spotlight (EIS) taking place on the 4th October 2023 at the RAI Amsterdam, preceding the EURETINA Annual Congress.

Ms. Megan Baldwin
Managing Director & CEO
OPTHEA

Mr. Pierre Billardon
CEO
DUTCH OPHTHALMIC RESEARCH CENTRE

Mr. Mikhail Boukhny
Global Head of R&D
BVI

Dr. Christopher Brittain
VP Global Head of Ophthalmology Product Development
GENENTECH

Ms. Anne Marie Cairns
Chief Clinical Officer
OPTOS

Mr. Victor Chong
VP, Global Head of Retina
JANSSEN R&D LLC

Dr. Thomas Ciulla
Chief Medical Advisor – Retina & Chair Scientific Advisory Board
CLEARSIDE BIOMEDICAL

Mr. Justin Creel
Head Targeted Therapeutics Delivery
NOVARTIS

Dr. Anupam Dalal
Chief Investment Officer
ACUTA CAPITAL PARTNERS

Mr. Andrew Dick
CEO
CIRRUS

Mr. George Elston
CFO
EYEPOINT PHARMA

Prof. Nicole Eter
—
UNIVERSITY OF MUNSTER

Mr. Sascha Fauser
Global Head of Ophthalmology
ROCHE

Dr. Laurent Fischer
President & CEO
ADVERUM BIOTECHNOLOGIES

Dr. Cedric Francois
President & CEO
APELLIS PHARMACEUTICALS USA

Dr. Mohamed Genead
Co-Founder, CEO & President
AVICEDA THERAPEUTICS INC.


Ms. Anta Gkelou
Principal Capital Strategy
SOFINNOVA PARTNERS

Dr. Ulrike Graefe-Mody
Global Head Retinal Health
BOEHRINGER INGELHEIM

Mr. Bernhard Guenther
CEO & Chairman of the Board
OPHTHOROBOTICS AG

Mr. Paul Hallen
VP Global Head Retina & Glaucoma
ALCON

Dr. Naama Hammel
Clinical Research Scientist
GOOGLE HEALTH

Mr. Yehia Hashad
EVP of R&D and CMO
BAUSCH + LOMB

Ms. Erin Henry
VP Product Strategy & Innovation
IVERIC BIO AN ASTELLAS COMPANY

Dr. Ralf Hornig
Clinical Affairs Director
PIXIUM VISION SA

Dr. Robert Kim
Chief Medical Officer
4D MOLECULAR THERAPEUTICS

Dr. Sergio Leal
Director, Global Clinical Leader
BAYER

Dr. Stephanie Magazzeni
Head of Digital Research and Innovation
ZEISS

Mr. Antony Mattessich
President & CEO
OCULAR THERAPEUTIX

Dr. Helge Menz
Assistant to the General Manager
PHARMPUR GMBH

Mr. Kester Nahen
CEO
NOTAL VISION

Dr. Grazia Pertile
—
IRCCS OSPEDALE, SPAIN

Prof. Tunde Peto
—
QUEENS’ UNIVERSITY BELFAST

Prof. Jose Carlos Pastor Jimeno
—
UNIVERSITY OF VALLADOLID, SPAIN

Prof. Mario Romano
—
HUMANITAS UNIVERSITY, MILAN

Dr. Mathias Schifflers
GMA Head of Eyecare
ABBVIE EYECARE

Mr. Ron Schneider
CEO Beyeonics Surgical
BEYEONICS

Ms. Arianna Schoess Vargas
Managing Director
HEIDELBERG ENGINEERING GMBH

DR. Riad Sherif
CEO
OCULIS

Mr. Christoph Spuhler
CEO
ACUSURGICAL

Dr. David Tanzer
Chief Medical Officer
OCUTERRA THERAPEUTICS

Mr. Blaise Thomson
CEO
BITFOUNT

Mr. Ramin Valian
Vice President-US Eye Care
ABBVIE

Mr. Edward Van Wezel
Managing Partner
BIOGENERATION VENTURES

Dr. Kerstin Wickstrom
Expert, Clinical Unit
ICELANDIC MEDICINES AGENCY

DR. Charles Wykoff
—
HOUSTON METHODIST HOSPITAL & BLANTON EYE INSTITUTE